Date published: 2026-5-2

1-800-457-3801

SCBT Portrait Logo
Seach Input

WDR13 Inhibitors

WDR13 inhibitors belong to a specific class of chemical compounds designed to target and modulate the activity of the WDR13 protein. The term "WDR13" stands for WD Repeat Domain 13, which is a protein characterized by the presence of multiple WD40 repeat domains. These WD40 repeat domains serve as protein-protein interaction modules, allowing WDR13 to participate in various cellular processes. WDR13 itself is known to play a role in various biological functions, including gene expression regulation, cell cycle progression, and protein degradation through the ubiquitin-proteasome pathway. Inhibitors of WDR13 are synthesized with the aim of disrupting or attenuating the protein's function, leading to alterations in cellular processes where WDR13 is involved.

WDR13 inhibitors can take on diverse forms, including small organic molecules or peptides, designed to bind to specific sites on the WDR13 protein, thereby interfering with its normal function. The structural diversity of these inhibitors allows for a range of approaches in designing molecules that can effectively disrupt WDR13 activity. Through extensive research and experimentation, scientists aim to elucidate the mechanisms by which WDR13 inhibitors interact with the protein and understand their impact on cellular pathways.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Inhibits mTOR pathway, which could intersect with WDR13-related signaling and protein synthesis control.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

Inhibits PI3K, upstream of mTOR signaling, potentially affecting WDR13 function indirectly.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Another PI3K inhibitor, could alter WDR13 function through modulation of PI3K-dependent pathways.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

HDAC inhibitor, could affect WDR13 by altering chromatin structure and gene expression.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

DNA methyltransferase inhibitor, potentially impacting WDR13 expression by epigenetic modulation.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

MEK inhibitor, could interfere with the MAPK/ERK pathway, which may intersect with WDR13 signaling.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor, potentially affecting pathways that WDR13 may be involved in.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

p38 MAPK inhibitor, could disrupt cellular processes involving WDR13.

Apocynin

498-02-2sc-203321
sc-203321A
sc-203321B
sc-203321C
1 g
10 g
100 g
500 g
$27.00
$68.00
$116.00
$360.00
74
(2)

Inhibits NADPH-oxidase, which could influence oxidative stress pathways linked to WDR13.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

ROCK inhibitor, could affect cytoskeletal dynamics, potentially influencing WDR13's cellular context.